Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28831199)

Published in Mol Psychiatry on July 25, 2017

Authors

Jinchen Li1, Lin Wang1, Hui Guo1, Leisheng Shi2, Kun Zhang2, Meina Tang1, Shanshan Hu2, Shanshan Dong1, Yanling Liu1, Tianyun Wang1, Ping Yu2, Xin He3, Zhengmao Hu1, Jinping Zhao4, Chunyu Liu1,5, Zhong Sheng Sun2,6, Kun Xia1,7

Author Affiliations

1: The State Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
2: Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
3: Department of Human Genetics, University of Chicago, Chicago, IL, USA.
4: Mental Health Institute, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
5: Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
6: Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
7: Key Laboratory of Medical Information Research, Central South University, Changsha, Hunan, China.

Articles cited by this

The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39

Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51

WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics (2008) 18.58

Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76

Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71

De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61

Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83

De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69

Spatio-temporal transcriptome of the human brain. Nature (2011) 9.19

Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science (2012) 6.21

The contribution of de novo coding mutations to autism spectrum disorder. Nature (2014) 5.94

Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet (2013) 5.58

Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30

Characterising and predicting haploinsufficiency in the human genome. PLoS Genet (2010) 4.85

A framework for the interpretation of de novo mutation in human disease. Nat Genet (2014) 4.00

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26

Transcriptional landscape of the prenatal human brain. Nature (2014) 3.05

Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell (2013) 2.94

Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell (2013) 2.87

Autism. Lancet (2013) 2.60

Microcephaly and macrocephaly in autism. J Autism Dev Disord (1999) 2.54

Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47

Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron (2013) 2.45

A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci (2013) 2.24

Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med (2015) 2.20

CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol (2008) 2.10

Disruptive CHD8 mutations define a subtype of autism early in development. Cell (2014) 2.05

De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry (2013) 1.93

Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron (2015) 1.91

SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry (2011) 1.79

A genotype-first approach to defining the subtypes of a complex disease. Cell (2014) 1.72

Mitotic and mitogenic Wnt signalling. EMBO J (2012) 1.62

Excess of rare, inherited truncating mutations in autism. Nat Genet (2015) 1.62

De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry (2014) 1.62

Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun (2014) 1.59

Properties and rates of germline mutations in humans. Trends Genet (2013) 1.58

Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet (2013) 1.53

SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol Autism (2013) 1.48

Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet (2013) 1.48

Advancing the understanding of autism disease mechanisms through genetics. Nat Med (2016) 1.45

Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry (2012) 1.27

Plexin signaling selectively regulates the stereotyped pruning of corticospinal axons from visual cortex. Proc Natl Acad Sci U S A (2008) 1.23

Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci (2014) 1.21

Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry (2013) 1.16

A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry (2012) 1.09

Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons. Mol Psychiatry (2014) 1.09

Genotype to phenotype relationships in autism spectrum disorders. Nat Neurosci (2014) 1.05

Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. Am J Hum Genet (2015) 1.03

Loss of δ-catenin function in severe autism. Nature (2015) 1.03

Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry (2015) 1.01

Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry (2013) 0.98

Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction. Mol Psychiatry (2013) 0.97

Genome-wide characteristics of de novo mutations in autism. NPJ Genom Med (2016) 0.92

Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling. Nat Neurosci (2016) 0.91

Common genetic variants on 1p13.2 associate with risk of autism. Mol Psychiatry (2013) 0.89

Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat Neurosci (2016) 0.87

Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin. Mol Psychiatry (2014) 0.86

Dysplastic spondylolysis is caused by mutations in the diastrophic dysplasia sulfate transporter gene. Proc Natl Acad Sci U S A (2015) 0.86

Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry (2015) 0.84

A scored human protein-protein interaction network to catalyze genomic interpretation. Nat Methods (2016) 0.84

Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nat Genet (2017) 0.84

Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry (2014) 0.83

Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations. Mol Psychiatry (2016) 0.82

Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic autism spectrum disorder. Mol Psychiatry (2015) 0.82

mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing. J Med Genet (2015) 0.82

Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism. Mol Psychiatry (2015) 0.81

Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis. Psychiatry Res (2015) 0.81

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci (2017) 0.80

De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun (2016) 0.78

The ciliogenic transcription factor Rfx3 is required for the formation of the thalamocortical tract by regulating the patterning of prethalamus and ventral telencephalon. Hum Mol Genet (2015) 0.76

Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging. Mol Neurobiol (2016) 0.76

Mutations in WNT10B Are Identified in Individuals with Oligodontia. Am J Hum Genet (2016) 0.75